Аустралија - Енглески - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - eimeria acervulina hp; eimeria maxima cp; eimeria maxima mfp; eimeria mitis hp; eimeria tenella hp - misc. vaccines or anti sera - eimeria acervulina hp vaccine-general active 500.0 ooc/dose; eimeria maxima cp vaccine-general active 200.0 ooc/dose; eimeria maxima mfp vaccine-general active 100.0 ooc/dose; eimeria mitis hp vaccine-general active 1000.0 ooc/dose; eimeria tenella hp vaccine-general active 500.0 ooc/dose - immunotherapy - poultry broilers (meat for human consum) | chickens | chooks | meat birds - coccidiosis - see label for causes | eimeria acervulina | eimeria arloingi | eimeria bovis | eimeria brunetti | eimeria christenseni | eimeria maxima | eimeria mitis | eimeria mivati | eimeria necatrix | eimeria ninakohlyakimovae | eimeria praecox | eimeria tenella | eimeria zuernii

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

astrazeneca limited - goserelin acetate 11.34mg equivalent to 10.8 mg goserelin;  ; bicalutamide 50mg - combination - 10.8mg+50mg pack - active: goserelin acetate 11.34mg equivalent to 10.8 mg goserelin   excipient: polyglactin active: bicalutamide 50mg excipient: hypromellose lactose macrogol 300 magnesium stearate povidone sodium starch glycolate titanium dioxide - zolacos cp is indicated for the treatment of advanced prostate cancer and prevention of disease flare associated with the use of lhrh agonists.

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

astrazeneca limited - goserelin acetate 3.8mg equivalent to 3.6 mg goserelin;  ; bicalutamide 50mg;   - combination - 3.6mg + 50mg pack - active: goserelin acetate 3.8mg equivalent to 3.6 mg goserelin   excipient: polyglactin active: bicalutamide 50mg   excipient: hypromellose lactose macrogol 300 magnesium stearate povidone sodium starch glycolate titanium dioxide - zolacos cp is indicated for the treatment of advanced prostate cancer and prevention of disease flare associated with the use of lhrh agonists.

Израел - Енглески - Ministry of Health

kamada ltd, israel - human hepatitis b immunoglobulin - solution for infusion - human hepatitis b immunoglobulin 50 mg / 1 ml - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - prophylaxis against hepatitis b in adults and children over 2 years of age who have not been vaccinated against hepatitis b (including persons whose vaccination is incomplete or missing) who are at risk of infection with hepatitis b by accidental contact with hepatitis b virus containing material following: - percutaneous exposure (e.g. accidental needle stick). - direct mucous membrane contact. when the administration of an intramuscular hepatitis b immunoglobulin is not possible. the immunoglobulin should be administered in association with hepatitis b vaccine. prophylaxis against re-infection of a transplanted liver in patients who carry the surface antigen of the hepatitis b virus. immunoprophylaxis of hepatitis b in the newborn of a hepatitis b virus carrier mother.

Нигерија - Енглески - NAFDAC (National Agency for Food and Drugs Administration and Control)

tamoxifen 20mg

Велика Британија - Енглески - DrWeigert

dr. weigert -

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - leuprorelin acetate, quantity: 22.5 mg - injection, modified release - excipient ingredients: polyglactin; n-methyl-2-pyrrolidone - bicalutamide,treatment of advanced prostate cancer in combination with lhrh agonist therapy.,leuprorelin,eligard? is indicated for the palliative treatment of advanced prostate cancer.

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - leuprorelin acetate, quantity: 7.5 mg - injection, modified release - excipient ingredients: n-methyl-2-pyrrolidone; polyglactin - bicalutamide,treatment of advanced prostate cancer in combination with lhrh agonist therapy.,leuprorelin,eligard? is indicated for the palliative treatment of advanced prostate cancer.

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - leuprorelin acetate, quantity: 22.5 mg - injection, modified release - excipient ingredients: n-methyl-2-pyrrolidone; polyglactin - bicalutamide,treatment of advanced prostate cancer in combination with lhrh agonist therapy.,leuprorelin,eligard? is indicated for the palliative treatment of advanced prostate cancer.

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

recell u korea - glycerin (unii: pdc6a3c0ox) (glycerin - unii:pdc6a3c0ox) - glycerin 10 g in 100 ml - skin protectant apply proper amount to the skin